[Epidemiologic approach in the treatment of constipation: the Mulkine example].
作者信息
Leymarios J
机构信息
Mulkine, Laboratoires Beaufour, Paris, France.
出版信息
Ann Gastroenterol Hepatol (Paris). 1988 Jan-Feb;24(1):33-7.
PMID:2833153
Abstract
摘要
相似文献
1
[Epidemiologic approach in the treatment of constipation: the Mulkine example].
Ann Gastroenterol Hepatol (Paris). 1988 Jan-Feb;24(1):33-7.
2
The evaluation of a new appetite-reducing agent (Prefil) in the management of obesity.
Br J Clin Pract. 1980 Mar;34(3):72-4.
3
[Evaluation of a new therapy (beidellian montmorillonite--guar gum) in the treatment of constipation].[一种新疗法（贝德连蒙脱石-瓜尔胶）治疗便秘的评估]
Ann Gastroenterol Hepatol (Paris). 1987 Jan-Feb;23(1):43-6.
4
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome.部分水解瓜尔胶在肠易激综合征治疗中的作用。
Nutrition. 2006 Mar;22(3):334-42. doi: 10.1016/j.nut.2005.10.003. Epub 2006 Jan 18.
5
Effect of supplements of partially hydrolyzed guar gum on the occurrence of constipation and use of laxative agents.部分水解瓜尔胶补充剂对便秘发生及泻药使用的影响。
J Am Diet Assoc. 1998 Aug;98(8):912-4. doi: 10.1016/S0002-8223(98)00210-7.
6
[The use of guar gum in treating hypercholesterolemia].[瓜尔豆胶在治疗高胆固醇血症中的应用]
Ter Arkh. 1991;63(8):70-2.
7
[Controlled study on the effect of guar on ambulatory type II diabetics].[瓜尔豆对非卧床II型糖尿病患者疗效的对照研究]
Beitr Infusionther Klin Ernahr. 1983;12:195-205.
8
[Multicenter study on the effect of guar on carbohydrate and lipid metabolism in ambulatory type II diabetics].[关于瓜尔胶对非住院II型糖尿病患者碳水化合物及脂质代谢影响的多中心研究]
Beitr Infusionther Klin Ernahr. 1983;12:177-94.
9
Guar gum, dietary fiber and diabetes.瓜尔豆胶、膳食纤维与糖尿病
Med Lett Drugs Ther. 1979 Jun 15;21(12):51-2.
10
[Guar therapy in diabetes mellitus].[瓜尔胶疗法治疗糖尿病]
Beitr Infusionther Klin Ernahr. 1983;12:152-64.
Zotero 插件